IAS 2023 Day 3 Dr. Bill Kapogiannis Talks About Priorities for the Office of AIDS Research

Day 1 at IAS 2023 Brian Minalga and Dr. Carl Dieffenbach Discuss Mpox & MoreПодробнее

Day 2 at IAS 2023 REPRIEVE Study and Long-Acting Treatment & Prevention OptionsПодробнее

Pharmacy-Centered HIV Research Meeting Day 1Подробнее

Day 3 Highlights from IAS 2023Подробнее

Donald Ritchie on the Need to Negotiate in the Senate (Discussion Topic 3)Подробнее

Day 4 Highlights from IAS 2023Подробнее

IAS 2023 Day 4 Louis Shackelford & Erica Crittendon on Conference Updates & HIV StigmaПодробнее

IAS 2023 Day 3 Dr. Carl Dieffenbach Shares Updates on HIV Vaccine Research & bnAbsПодробнее

Topic 3. Audience DiscussionПодробнее

Know your place part 3: what class means nowПодробнее

Plenary 3 - Spotlight: Governments Can Drive InspirationПодробнее

Living with HIV and HPV IAS 2023 pre-meeting Session 3Подробнее

2023 HIV Cure & Immunotherapy Forum – Session 3: Gene and cell therapyПодробнее

Nuremberg Forum 2024 - Panel IIIПодробнее

Careium | Q3 presentation by CEO Christian Walén and CFO David Granath - Q&A followsПодробнее

Report Back from the International AIDS Conference (IAS) 2023Подробнее